MedPath

MYLAN PHARMACEUTICALS INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Food Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mg

First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
24
Registration Number
NCT00649649
Locations
🇺🇸

PRACS Institute, Ltd., Fargo, North Dakota, United States

Fasting Study of Escitalopram Oxalate Tablets 20 mg and Lexapro® Tablets 20 mg

First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
37
Registration Number
NCT00648570
Locations
🇺🇸

Kendle International Inc., Morgantown, West Virginia, United States

Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg

First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
21
Registration Number
NCT00647634
Locations
🇺🇸

Kendle International Inc., Morgantown, West Virginia, United States

Fasting Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg

First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
28
Registration Number
NCT00649363
Locations
🇺🇸

Kendle International Inc., Morgantown, West Virginia, United States

Food Study of Modafinil Tablets 200 mg to Provigil® Tablets 200 mg

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
20
Registration Number
NCT00650286
Locations
🇺🇸

Kendle International Inc., Morgantown, West Virginia, United States

Food Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
66
Registration Number
NCT00650403
Locations
🇺🇸

Gateway Medical Research, Inc., Saint Charles, Missouri, United States

Fasting Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-04-01
Last Posted Date
2024-04-23
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
107
Registration Number
NCT00650052
Locations
🇺🇸

Kendle International Inc., Morgantown, West Virginia, United States

Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr

Phase 1
Terminated
Conditions
Healthy
Interventions
Drug: Mylan Fentanyl Transdermal System 25 mcg/h + Clinical Procedure 1
Drug: Mylan Fentanyl Transdermal System 25 mcg/h + Clinical Procedure 2
Drug: Mylan Fentanyl Transdermal System 25 mcg/h + Clinical Procedure 3
First Posted Date
2008-04-01
Last Posted Date
2024-04-23
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
12
Registration Number
NCT00648414
Locations
🇺🇸

Kendle International Inc., Morgantown, West Virginia, United States

Fed Study of Metoprolol Tartrate Tablets 25 mg and Lopressor® 50 mg

First Posted Date
2008-04-01
Last Posted Date
2024-04-23
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
19
Registration Number
NCT00648271
Locations
🇺🇸

Kendle International Inc., Morgantown, West Virginia, United States

Fasting Study of Cetirizine HCl Tablets 10 mg and Zyrtec® Tablets 10 mg

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
26
Registration Number
NCT00650065
Locations
🇺🇸

Novum Pharmaceutical Research Services, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath